SMAD4 and hepatocellular carcinoma: Interestingly, we found significantly higher percentage of TP53/SMAD4 mutations and IDH/FGFR2-fus/BAP1 mutations, while lower mutation rate of CTNNB1 in CLHCC subtype than classical HCC subtype (Figure 5A).